






Vol.2 , No. 3, Publication Date: Aug. 7, 2015, Page: 13-20
[1] | Ugoeze K. C., Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Port Harcourt, Nigeria. |
[2] | Nkoro V. O., Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Port Harcourt, Nigeria. |
A study of the physico-technical properties of a novel co-processed multicomponent Lentinus tuber regium (LTR) based excipient (fizlent) designed to improve flowability and compressibility of LTR was carried out. A wet mass obtained by solvent evaporation of alcoholic dispersions of LTR, sodium bicarbonate, tartaric and citric acids in proportions of 80, 10, 6.5, 3.5 % w/w respectively was granulated, dried at 60º C and classified with 250µm sieve. Densities (bulk, tapped and particle), flow properties (flow rate, angle of repose, Carr’s index, Hausner’s ratio), swelling index, hydration capacity, differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and pH were determined for the natural, processed LTR and fizlent. Fizlent appeared as a compactable, tasteless, off-white powder without distinct odour. Aqueous dispersion of it has pH of 6.92 ± 0.13. Results show that a new pharmaceutical grade co-processed excipient, fizlent with enhanced flow, compressibility and dilution potential of 70-80% (paracetamol) and ≤ 30% for metronidazole, ascorbic acid and ibuprofen respectively was developed by particle engineering of Lentinus tuber regium, citric acid, tartaric acid and sodium hydrogen carbonate. Fizlent may be a useful filler-binder with potentials as directly compressible powder especially for most low dose drugs and may possibly serve as superdisintegrant.
Keywords
Physico-Technical, Multicomponent, Lentinus tuber regium, Co-processed, Excipient, fizlent
Reference
[01] | Chukwu A (2001). Key points in pharmaceutical formulation and industrial pharmacy. Mike Social Press, Nsukka, Nigeria, 1-5. |
[02] | Okore VC, Adikwu MU (2009). Application of polymers in pharmaceutical sciences. In: Polymers and polymer applications. Attama AA and Esimone COE (editors), Jolyn Publishers, Nsukka, Nigeria, 49-63 |
[03] | Shangraw RF (1997). Emerging trends in the use of pharmaceutical excipients. Pharm. Technol. 21 (6): 36-42. |
[04] | Moreton RC (1996). Tablet excipients to the year 2001: A look into the crystal ball. Drug Dev. Ind. Pharm. 22 (1):11-23. |
[05] | Reimerdes D, Aufmuth KP (1992). Tableting with coprocessed lactose-cellulose excipient. Manufacturing Chemist, 63 (12):23-24. |
[06] | Nachaegari SK, Bansal AK (2004). Coprocessed excipients for solid dosage forms. Pharmaceutical Technology, 28:52-64. |
[07] | Gohel MC, Jogani PD (2005). A review of co-processed directly compressible excipients. Journal of Pharmacy and Pharmaceutical Science, 8(1): 76-93. |
[08] | Michael J, Tobyn GP, McCarthy I, John N, Staniforth SE (1998). Physicochemical comparison between microcrystalline cellulose and silicified microcrystalline cellulose. Int. J. Pharm. 169: 183-194. |
[09] | York P (1998). Crystal engineering and particle design for the powder compaction process. Drug Dev. Ind. Pharm. 18(6, 7): 677-721. |
[10] | Belda PM, Mielck JB (1996). The tableting behavior of cellactose compared with mixtures of celluloses with lactoses. Eur. J. Pharm. Biopharm; 42 (5):325-330. |
[11] | Schmidt PC, Rubensdorfer CJW (1994). Evaluation of ludipress as a multipurpose excipient for direct compression part I: powder characteristics and tableting properties. Drug Dev. Ind. Pharm; 20 (18): 2899-2925. |
[12] | Bolhuis GK, Chowhan ZT (1996). Materials for direct compression. In: Pharmaceutical powder compaction technology, Vol-7, Marcel Dekker, USA, 419-499. |
[13] | Kumar T, Gupta SK, Prajapati MK, Tripathi DK, Sharma V, Jain P (2012). Natural excipients: a review. Asian Journal of Pharmacy and Life Sciences 2(1):97-108. |
[14] | Tuovinen L, Peltonen S, Jarvinen K (2003). Drug release from starch-acetate films. J. Control Release 91: 345-354 |
[15] | Okhamafe AO, Azubuike CPC (1994). Direct compression studies on low-cost cellulose derived from maize cob. Journal of Pharmaceutical Sciences and Pharmacy Practice 2:26-29. |
[16] | Iwuagwu MA, Onyekweli AO (2002). Preliminary investigation into the use of Pleurotus tuber-regium powder as a tablet disintegrant. Tropical Journal of Pharmaceutical Research, 1 (1): 29-37. |
[17] | Okhuoya JA, Etugo JA (1993). Studies on the cultivation of Pleurotus tuber-regium (Singer), an edible mushroom. Bioresource Technology 41: 1-3. |
[18] | Gbolagade J, Ajayi A, Oku I, Wankasi D (2006). Nutritive value of common wild edible mushrooms from southern Nigeria. Global Journal of Biotechnology and Biochemistry 1(1):16-21. |
[19] | Okhuoya JA, Okogbo FO (1991). Cultivation of Pleurotus tuber-regium (Fr) Sing on various farm wastes. Proc. Okla. Acad. Sci. 71:1- 3. |
[20] | Ikewuchi CC, Ikewuchi JC (2009). Chemical profile of Pleurotus tuber regium (Fr) Sing’s sclerotia. Pacific Journal of Science and Technology 10(1):295-299. |
[21] | Ukoima HN, Ogbonnaya L, Anikpo GE, Pepple GA (2009). Nutritional, organoleptic and palatability studies of selected edible mushrooms in Nigeria. World Applied Sciences Journal 7(4): 479-484. |
[22] | Ugoeze KC, Nwaokenye C, Ibezim CNE (2013). Studies on the disintegrant and drug release rate enhancing properties of admixtures of corn starch BP and Lentinus tuber - regium powders in wet granulated paracetamol tablet. African Journal of Pharmaceutical Research and Development 5(2):83-90. |
[23] | Ugoeze KC, Okpara C (2015). Characterization of a novel coprocessed powder of Lentinus tuber regium and polyvinylpyrollidone (Povilent). International Research Journal of Pharmaceutical and Applied Sciences 5(2):15-21. |
[24] | Chougule AS, Dikpati A, Trimbake T (2012). Formulation development techniques of co-processed excipients. Journal of Advanced Pharmaceutical Sciences 2(2): 149-231. |
[25] | Odeku OA, Awe OO, Popoola B, Odeniyi MA, Itiola OA (2005). Compression and mechanical properties of tablet formulations containing corn, sweet potato and cocoyam starches as binders. Pharm. Technol. 29(4): 82-90. |
[26] | Carstensen JT, Chan FC (1997). Flow rates and repose angle of wet-processed granulations. J. Pharm. Sci. 66: 1235. |
[27] | Jones TM, Pilpel N (1996). The flow properties of granular magnesia. J. Pharm. Pharmacol. 18: 81-93. |
[28] | Zeleznik JA, Renak JL (2001). Flow and compact properties of dibasic calcium phosphate blended with microcrystalline cellulose and silicified microcrystalline cellulose: a paper presented at the American Association of Pharmaceutical Scientists Annual Meeting and Exposition, Denver, Colorado. |
[29] | Hausner H (1967). Friction conditions in a mass of metal powder. International Journal of Powder Metallurgy 3:7-13. |
[30] | Carr R (1965). Classifying flow of solids. Chemical Engineering 72:69-72 |
[31] | Ring SG (1985). Some Studies on Gelatin. Starch 37:80-87. |
[32] | Bowen FE, Vadino WA (1984). A simple method for differentiating sources. Drug Dev. Ind. Pharm. 10: 505 – 511. |
[33] | Iwuagwu MA, Okoli PC (1992). The disintegrant properties of pregelatinized cassava and white yam starch. Pharm. World J. 9: 49 – 53. |
[34] | The United States Pharmacopoeia, U.S.P/ NF (2009). The United States Pharmacopeial Convention, Rockville, 127-129, 134-135, 688-690. |
[35] | Well J (2003). Pharmaceutical preformulation: the physicochemical properties of drug substances. In: Aulton, M.E. (Ed.). The science of dosage form design, 2nd ed. Churchill Livingstone, Toronto, 113–138. |
[36] | Neumann BS (1967). Advances in pharmaceutical sciences, Vol. 2; Bean, H.S.; Beckett, A.H. & Carless, J.E. (eds.), Academic Press, London, 181 |
[37] | Pilpel N (1964). The flow properties of magnesia. J. Pharm. Pharmac. 16: 705 |